Antisera have been prepared against purified proteoglycan monomer and link protein from bovine cartilages. The immunological properties of these species have been studied by immunodiffusion, Laurell rocket immunoelectrophoresis, crossed immunoelectrophoresis, hemagglutination, and immunofluorescence. Antisera raised against either adult bovine articular or foetal bovine epiphyseal proteoglycan monomer were monospecific. They did not react with link protein, type II collagen, nor with any other molecular species isolated from bovine articular and epiphyseal cartilages. Antisera to link protein, purified from bovine nasal cartilage by dissociative density gradient centrifugation followed by chromatography under dissociative conditions on Sephacryl S-200, showed no reaction with proteoglycan monomer by immunodiffusion. However, antisera to link protein showed a weak reaction with native monomer on Laurell rocket immunoelectrophoresis (not detectable when chondroitinase ABC-treated monomer was used), and with chondroitinase ABC-treated monomer by hemagglutination assay. These traces of antibody to proteoglycan monomer were inactivated by immunoreaction with proteoglycan monomer in solution to provide a monospecific antiserum to link protein. Purified antibodies specific for proteoglycan monomer, some of which did not react with the hyaluronic acid binding region of bovine nasal monomer, were prepared from anti-link sera by affinity chromatography using chondroitinase ABC-treated bovine nasal proteoglycan monomer. Purified link protein, which contains 48,000- and 44,000-dalton subunits, contains two immunologically distinguishable species. An immunoassay for purified link protein was developed using Laurell rocket electrophoresis. A micro-method, using crossed-immunoelectrophoresis, for studying the binding of link protein to proteoglycan monomer and to hyaluronate is described. The complex of link protein bound to hyaluronate was dissociated on reaction of link protein with antibody.
Download full-text PDF |
Source |
---|
Biomolecules
November 2024
Department of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Neuropharmacology
January 2025
Department of Anesthesiology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address:
Biomolecules
October 2024
Department of Surgical and Interventional Sciences, McGill University, Montreal, QC H3T 1E2, Canada.
Bone
January 2025
Julius Wolff Institute, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany. Electronic address:
Treatment of bone fractures are standardized according to the AO classification, which mainly refers to the mechanical stabilization required in a given situation but neglect individual differences due to patient's healing potential or accompanying diseases. Specially in elderly or immune-compromised patients, the complexity of individual constrains on a biological as well as mechanical level are hard to account for. Here, we introduce a novel framework that allows to predict bone regeneration outcome using combined proteomic and mechanical analyses in a computer model.
View Article and Find Full Text PDFBiochem J
October 2024
Centre de recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Division Oncologie, Québec, QC, Canada.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!